The Central Luzon Health Research and Development Consortium (CLHRDC) is pleased to announce its call for capsule research proposals in the field of health R&D for possible funding in FY 2014 by the Philippine Council for Health Research and Development (PCHRD) of the DOST. This program is open to all interested researchers and faculty members from the CLHRDC member-institutions.
PCHRD is offering funding support under the Regional Research Fund mechanism up to a maximum amount of PhP 300,000.00 for a qualified project. This fund is a tool to encourage new researchers to be actively involved in health research activities without having to compete with more experienced researchers and obtain experience by implementing simple yet relevant health research projects. It also encourages research collaboration among state universities and colleges (SUCs), private higher education institutions and government R&D institutes in the region.
In order to be eligible for funding assistance under the RRF, research proposals must be aligned with the 2011-2016 Research Priorities of the PCHRD. Proposals will be selected and endorsed to PCHRD after undergoing evaluation by the CLHRDC Research Management and Ethics Review Committees. The priority research areas include the following:
1. Drug Discovery and Development:
Discovery of new drugs from natural substances (herbal and marine/terrestrial sources) which can be developed up to the pre-clinical stage for common infectious diseases and lifestyle-related disorders.
2. Development of Diagnostic kits for Priority Diseases:
Development of diagnostic tests (point of care and confirmatory) for priority infectious and lifestyle-related diseases for the early detection and/or prediction of disease and mortality, utilizing existing technologies that are off-patent or lapsed technology and/or novel technology.
(dengue and dengue-like illnesses; MDR/XTR TB; drug-resistant malaria; influenza-like illnesses leptospirosis; sepsis; myocardial infarction; colorectal cancer; stroke, diabetes mellitus; and breast cancers )
3. Genomic and Molecular Technology:
Use of information in the human genome in the design of vaccines, therapeutics, and diagnostic devices or products.
(e.g. biomarkers for early detection of diseases and target markers for treatment; personalized medicine; adult stem cells; biologics)
4. ICT for Health:
Development of user-friendly ICT solutions to accelerate the gathering and processing of health-related information for policy making and to deliver quality health care services.
(e.g. Public health surveillance/health intelligence systems; telehealth services and systems; interface for ICT-enabled devices)
5. Hospital Equipment and Biomedical Devices:
Development of affordable, safe and reliable hospital equipment and biomedical devices. (e.g. ventilator/respirator; prosthesis; minimally-invasive surgery and rehabilitation equipment and e=instruments using optics and robotics)
Aside from PCHRD, qualified proposals may also be endorsed by the consortium to other funding agencies such as the DOH-III, CHED-III and DOST-III.
Capsule proposals should be submitted to the Central Luzon Health Research and Development Consortium, Department of Science & Technology Regional Office No. III, DM Government Center, Barangay Maimpis, City of San Fernando, Pampanga on or before January 15, 2014.
